CONSOLIDATED STATEMENTS OF EARNINGS - USD ($) $ in Thousands		12 Months Ended
		Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Net sales		$ 4,036,605	$ 4,032,853	$ 3,250,792
Cost of Sales		2,502,543	2,586,299	2,055,932
Gross profit		1,534,062	1,446,554	1,194,860
Selling, General and Administrative Expense		806,946	797,234	667,976
Restructuring Charges		14,134	9,716	7,655
Impairments		78,114	0	0
Merger termination fee		0	0	(110,000)
Gain on sale of plant		0	0	(763)
Income from operations	[1]	634,868	639,604	629,992
Net interest expense and deferred financing amortization, net		120,348	88,977	57,157
Net Periodic Benefit Cost, Other Than Service Cost & Curtailment		(9,071)	(42,681)	(45,066)
Other expense (income), net		4,213	28,893	(1,603)
Earnings before income taxes		519,378	564,415	619,504
Provision for income taxes		118,496	127,846	131,012
Net earnings		$ 400,882	$ 436,569	$ 488,492
Net earnings per share:
Basic (in usd per share)		$ 7.48	$ 8.07	$ 8.85
Diluted (in usd per share)		$ 7.41	$ 7.95	$ 8.62
Weighted average number of shares
Basic (in shares)		53,577,000	54,095,000	55,216,000
Dilutive common stock equivalents (in shares)		509,000	852,000	1,449,000
Diluted (in shares)		54,086,000	54,947,000	56,665,000

[1] Restructuring expenses and impairments are included in operating income of the segment to which they pertain. See note 3(f) and 12 for further details